Gainesville, FL – March 20th, 2019 Antibiotic Adjuvant announced today that Jeff Goodman will join the company as a Marketing and Sales Advisor.
Jeff has extensive entrepreneurial experience, as well as expertise in business leadership, strategic plan creation and execution, sales management and performance improvement.
Jeff’s passion is creating and leading customer-focused sales programs from a seasoned general management perspective. He relies heavily on analytics and creates innovative team-oriented solutions. CoreStrength, Jeff’s 16-year-old consulting company, has a history of managing sales for market leaders, including Johnson & Johnson, and innovators like Zila Pharmaceuticals.
“Antibiotic Adjuvant’s real time solution helps facilities enjoy healthier patient outcomes while reducing costs at the facility. I am thrilled to be part of an outstanding team dedicated to transforming infection control protocols at the local level,” says Jeff.
Prior to CoreStrength, Jeff was president of Dent-X, president of Espe America, and vice president of marketing of Benco Dental. Jeff was also the CEO and founder of the dental industry’s first online marketplace, Dexpo.com.
Jeff has a Bachelor of Arts from Muhlenberg College and a Master of Business Administration from Northeastern University.
About Antibiotic Adjuvant: Antibiotic Adjuvant improves patient health and reduces the cost of care in skilled nursing facilities. SmartSteward, Antibiotic Adjuvant’s initial product, is an intelligent digital platform which combines real-time communication with big data to streamline antibiotic stewardship and infection control.